Intravenous Iron Drugs Market Growth Analysis and Forecast to 2032

According to FMI, the global intravenous iron drugs market was valued at $2.6 billion in 2021 and is expected to reach $6.3 billion by 2032. According to the report's findings, Intravenous Iron Drugs revenue generated by Ferric Carboxymaltose will be in high demand in the market, as they will generate the majority of revenue.

According to the American Heart Association, more than 130 million adults in the United States will have cardiovascular disease by 2035. Furthermore, the Centers for Disease Control and Prevention reports that heart disease kills 0.6 million Americans each year. This data is directly related to the number of hospital admissions.

Due to its expanding use, improved performance, and lower cost, the Ferric Carboxymaltose (FCM) segment led the market for intravenous iron medicines in 2021, with nearly 50% revenue share. It is a dextran-free parenteral iron medication recommended for the rapid and high-dose replacement of depleted iron reserves. This medication is a stable compound that has the advantage of not containing any extraneous ingredients and having a very low immunogenic potential, posing a very low risk of anaphylactic reactions. FCM is more effective at increasing haemoglobin levels and has fewer side effects. The massive increase may also be attributed to the FDA's approval of injectables in North America, as well as approval outside of North America.

The region's growing senior population is a major driver of industry growth. According to US Census Bureau projections, the number of Americans aged 65 and older will increase from 52 million in 2018 to approximately 95 million by 2060. Furthermore, the overall proportion of people aged 65 and up is expected to rise from 16% to 23%.

It could be linked to a higher incidence of cancer, intestinal illnesses, and renal disease in the area. These circumstances also contribute to its dominance. It has also contributed to the increased awareness of women's health and celiac disease.

Competitive Landscape

Some of the major players in the global Intravenous Iron Drugs market are as follows: Vifor Pharma Management Ltd.; AMAG Pharmaceuticals; Daiichi Sankyo Company, Ltd.; Sanofi S.A.; Pharmacosmos A/S; Shield Therapeutics Plc; AbbVie Inc., Vifor Pharma Management Ltd.; AMAG Pharmaceuticals; Daiichi Sankyo Company, Ltd.; Sanofi S.A.; Pharmacosmos A/S; and Shield Therapeutics Plc among others.

Read More@ https://www.futuremarketinsights.com/reports/intravenous-iron-drugs-market

Market Segments Covered in Intravenous Iron Drugs Industry Analysis

By Product Type:

  • Iron Dextran
  • Iron Sucrose
  • Ferric Carboxymaltose
  • Other Product Types

By Indication:

  • Chronic Kidney Disease
  • Inflammatory Bowel Disease
  • Cancer
  • Other Applications

Comments

Post a Comment

Popular posts from this blog

Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

Image
According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033. Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world. Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to prod...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Cognitive Diagnostics Market Projected to Reach Unprecedented Growth by 2033

Image
As per Future Market Insights latest industry analysis, the valuation for the global  Cognitive Diagnostics market sales  is estimated to reach US$ 110.2 Billion in 2023 and is projected to exhibit a CAGR of 8.0% over the forecast period, with an estimated valuation of US$ 238.3 Billion by 2033. Several causes of brain problems or cognitive disorders include closed head injuries, contact with neurotoxins (toxic substances), genetics, infections, strokes, and tumours. Depending on the area of the brain that is impacted, a person may have a certain form of cognitive problem. Communication issues could result from, for instance, a tumour in the speech cisterns of the brain. In another illustration, a brain infection that affects the motor recentres would cause problems with movement. Ageing is also a factor in the development of cognitive problems. Cognitive diagnostics increasingly use digital health technologies like wearables and smartphone apps. These tools can monitor a pati...
Read more